Rekseal Injection

Introduction

Rekseal is a prescription medication that contains the active ingredient n-Butyl-2-cyanoacrylate. It is available under the brand name Rekseal. This medication is primarily used for the treatment of skin lacerations and surgical incisions that require closure. It is a liquid adhesive that forms a strong bond when applied to the skin.

Uses

Rekseal is prescribed for the closure of skin lacerations and surgical incisions. It is commonly used in medical settings, such as hospitals and clinics, to secure the edges of wounds and promote healing. This medication can be used for both small and large wounds, providing an effective alternative to traditional sutures or staples.

Dosage and Administration

Rekseal should be administered by a healthcare professional. The dosage and application method may vary depending on the size and location of the wound. The healthcare professional will apply the medication directly to the edges of the wound, ensuring proper closure and adhesion. Follow the healthcare professional’s instructions regarding the amount of medication to be used and the frequency of application.

Mechanism of Action

The active ingredient in Rekseal, n-Butyl-2-cyanoacrylate, works by polymerizing and forming a strong adhesive bond when it comes into contact with moisture, such as the fluids present in a wound. This adhesive bond helps to hold the edges of the wound together, allowing for proper healing. The adhesive film created by the medication provides a protective barrier that helps to prevent infection and promote the natural healing process.

Side Effects

Common side effects may include skin irritation, redness, or a burning sensation at the site of application. These side effects are generally mild and temporary. However, if you experience any severe or persistent side effects, such as severe pain, swelling, or signs of infection, seek medical attention immediately.

Drug Interactions

There are currently no known drug interactions associated with Rekseal. However, it is always important to inform your healthcare professional about all the medications you are taking, including prescription and over-the-counter drugs, as well as any herbal supplements or vitamins. This will help ensure the safe and effective use of Rekseal.

Precautions

Before using Rekseal, inform your healthcare professional if you have any known allergies to cyanoacrylates or any other ingredients in the medication. Additionally, let your healthcare professional know if you have any underlying medical conditions or if you are taking any other medications. This information will help your healthcare professional determine if Rekseal is the right treatment option for you.

Storage

Rekseal should be stored in a cool, dry place, away from direct sunlight and heat sources. It should be kept out of the reach of children and pets. Do not freeze the medication. Always check the expiration date before using Rekseal and discard any expired medication.

Patient Tips

• Follow the instructions provided by your healthcare professional regarding the application of Rekseal.
• Avoid touching or scratching the treated area to ensure proper adhesion and healing.
• If you experience any unusual or concerning symptoms after using Rekseal, contact your healthcare professional for further guidance.
• Keep the treated area clean and dry to promote healing and prevent infection.
• If you have any questions or concerns about Rekseal, do not hesitate to reach out to your healthcare professional for clarification.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Permanent make-up (NHS UK) [Accessed 6 Jun. 2024] (online) Available at:
• GLUture Topical Tissue Adhesive for Animal Use (Canada) (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at:
• Takao H, Abe O. Triple-balloon-assisted n-butyl-2-cyanoacrylate embolization of a cirsoid renal arteriovenous malformation. Vasa. 2020 Mar;49(2):147-150. doi: 10.1024/0301-1526/a000817. Epub 2019 Aug 15. [Accessed 21 Jun. 2024] Available at:
• Type 2 diabetes (NHS UK) [Accessed 9 Jun. 2024] (online) Available at: